Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Maternal Care and Infant Health After Noneconomic Damage Cap Repeals.

JAMA network open·2026
Same author

Impact of Prenatal Cell-Free DNA Screening on Sex Chromosome Aneuploidy Diagnoses in Infants and Children.

Prenatal diagnosis·2026
Same author

Cardio-Obstetrics Fundamentals for Fellows: A Digital Solution for Democratizing Cardio-Obstetric Education.

JACC. Advances·2026
Same author

Development, Testing, and Calibration of LINCS: A New Microsimulation Model of Maternal and Fetal Cytomegalovirus Infection in the United States.

MDM policy & practice·2026
Same author

Corrigendum to 'Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in Pregnancy: Updated Guidelines' [American Journal of Obstetrics and Gynecology 230/4 (2024) B2-B11].

American journal of obstetrics and gynecology·2026
Same author

Obstetric Service Availability and Travel Time to Access Obstetric Services in the U.S., 2010-2021.

American journal of preventive medicine·2026
Same journal

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation.

American journal of perinatology·2026
Same journal

WIC Participation and the Education-Related Gap in Adverse Neonatal Outcomes: A Population-Based Cohort Study.

American journal of perinatology·2026
Same journal

Low-Dose Aspirin Prophylaxis for Preeclampsia and the Risk of Postpartum Hypertensive Outcomes: A Propensity Score Analysis.

American journal of perinatology·2026
Same journal

Cystic Periventricular Leukomalacia in Preterm Infants: Clinical Risks, Heart Rate, and Oxygenation Patterns.

American journal of perinatology·2026
Same journal

International consensus curriculum and competency framework for maternal point-of-care ultrasound training.

American journal of perinatology·2026
Same journal

From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU.

American journal of perinatology·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

28.1K

Fetal Growth Restriction: A Pragmatic Approach.

Allan Nadel1, Malavika Prabhu1, Anjali Kaimal2

  • 1Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

American Journal of Perinatology
|November 25, 2024
PubMed
Summary
This summary is machine-generated.

Accurate diagnosis of fetal growth restriction (FGR) requires precise gestational age estimation. Daily electronic fetal heart rate monitoring is crucial for managing FGR with abnormal umbilical artery Doppler, without needing computer interpretation.

More Related Videos

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
10:12

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model

Published on: October 31, 2012

16.4K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

28.1K
A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
10:12

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model

Published on: October 31, 2012

16.4K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.5K

Area of Science:

  • Perinatology
  • Maternal-Fetal Medicine
  • Obstetrics

Background:

  • Accurate diagnosis of fetal growth restriction (FGR) is essential for optimal pregnancy management.
  • Precise estimation of gestational age via history and early ultrasound is critical, as minor dating errors can significantly impact diagnosis.
  • Risk stratification for adverse outcomes involves gestational age certainty, comorbidities, estimated fetal weight percentile, and umbilical artery waveform analysis.

Purpose of the Study:

  • To outline the diagnostic criteria and optimal surveillance strategies for fetal growth restriction.
  • To emphasize the importance of accurate gestational dating in diagnosing FGR.
  • To clarify the role of various monitoring techniques in managing FGR.

Main Methods:

  • Review of existing literature and clinical trial data, including the TRUFFLE trial.
  • Analysis of diagnostic parameters such as gestational age, estimated fetal weight, and umbilical artery waveform.
  • Evaluation of surveillance methods including electronic fetal heart rate monitoring, biophysical profile, and Doppler waveforms (ductus venosus, middle cerebral artery).

Main Results:

  • Optimal management of FGR with abnormal umbilical artery waveform necessitates daily electronic fetal heart rate monitoring.
  • Computerized interpretation is not required for electronic fetal heart rate monitoring in FGR surveillance.
  • The utility of ductus venosus waveform, biophysical profile, and middle cerebral artery waveform in FGR management is less established and should be interpreted cautiously.

Conclusions:

  • Precise gestational age estimation is fundamental for diagnosing fetal growth restriction.
  • Daily electronic fetal heart rate monitoring is the primary surveillance method for FGR when umbilical artery Doppler is abnormal.
  • While other monitoring modalities exist, their role is secondary to electronic fetal heart rate monitoring in specific FGR scenarios.